Postmastectomy radiation: A modest benefit prevails for high risk patients

Cancer

Volumn 79, Issue 6, 1997, Pages 1061-1066

  Fowble, B ^a   Olson, J E ^a   Neuberg, D ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FLUOXYMESTERONE; TAMOXIFEN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; EDITORIAL; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; PRIORITY JOURNAL;

EID: 0030933475     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970315)79:6<1061::AID-CNCR1>3.0.CO;2-J     Document Type: Editorial

References (54)